Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Genetics

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 24 articles: HTML format

Single Articles

February 2026
1. AKTAS SAMUR A, Corre J, Talluri S, Shah P, et al
   Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma.
   J Clin Oncol. 2026;44:321-334.
   PubMed     Abstract available
   
   
   January 2026
2. MAURA F, Bergsagel PL, Ziccheddu B, Kumar S, et al
   Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
   J Clin Oncol. 2026;44:188-199.
   PubMed     Abstract available
   
   
   February 2025
3. LEONG IUS, Cabrera CP, Cipriani V, Ross PJ, et al
   Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice.
   J Clin Oncol. 2025;43:682-693.
   PubMed     Abstract available
   
   
   January 2025
4. YU EY, Rumble RB, Agarwal N, Cheng HH, et al
   Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.
   J Clin Oncol. 2025 Jan 9:JCO2402608. doi: 10.1200/JCO-24-02608.
   PubMed     Abstract available
   
   
   October 2024
5. GOEL N, Hernandez A, Cole SW
   Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes.
   J Clin Oncol. 2024;42:3618-3627.
   PubMed     Abstract available
   
   
   August 2024
6. TENTORI CA, Gregorio C, Robin M, Gagelmann N, et al
   Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.
   J Clin Oncol. 2024;42:2873-2886.
   PubMed     Abstract available
   
   
   
7. CHANG TC, Chen W, Qu C, Cheng Z, et al
   Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.
   J Clin Oncol. 2024 Aug 9:JCO2302238. doi: 10.1200/JCO.23.02238.
   PubMed     Abstract available
   
   
   
8. YOSHIMURA S, Li Z, Gocho Y, Yang W, et al
   Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia.
   J Clin Oncol. 2024 Aug 5:JCO2400500. doi: 10.1200/JCO.24.00500.
   PubMed     Abstract available
   
   
   July 2024
9. KATZ SJ, Abrahamse P, Furgal A, Hodan R, et al
   Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
   J Clin Oncol. 2024 Jul 15:JCO2400122. doi: 10.1200/JCO.24.00122.
   PubMed     Abstract available
   
   
   June 2024
10. NGUYEN NH, Dodd-Eaton EB, Corredor JL, Woodman-Ross J, et al
    Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data.
    J Clin Oncol. 2024;42:2186-2195.
    PubMed     Abstract available
    
    
    
11. MIKOLAJEWICZ N, Yee PP, Bhanja D, Trifoi M, et al
    Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
    J Clin Oncol. 2024;42:1961-1974.
    PubMed     Abstract available
    
    
    April 2024
12. MAURA F, Rajanna AR, Ziccheddu B, Poos AM, et al
    Genomic Classification and Individualized Prognosis in Multiple Myeloma.
    J Clin Oncol. 2024;42:1229-1240.
    PubMed     Abstract available
    
    
    
13. SHRIVER SP, Adams D, McKelvey BA, McCune JS, et al
    Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
    J Clin Oncol. 2024;42:1181-1192.
    PubMed     Abstract available
    
    
    February 2024
14. TRAVIS LB, Feldman DR, Fung C, Poynter JN, et al
    Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.
    J Clin Oncol. 2024;42:696-706.
    PubMed     Abstract available
    
    
    January 2024
15. RICCIUTI B, Lamberti G, Puchala SR, Mahadevan NR, et al
    Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2024 Jan 11:JCO2300580. doi: 10.1200/JCO.23.00580.
    PubMed     Abstract available
    
    
    December 2023
16. JAGSI R, Griffith KA, Harris EE, Wright JL, et al
    Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
    J Clin Oncol. 2023 Dec 7:JCO2302270. doi: 10.1200/JCO.23.02270.
    PubMed     Abstract available
    
    
    November 2023
17. MANDELKER D, Marra A, Zheng-Lin B, Selenica P, et al
    Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.
    J Clin Oncol. 2023;41:5151-5162.
    PubMed     Abstract available
    
    
    
18. KILBRIDE M, Egleston BL, Chung WK, Olopade O, et al
    Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.
    J Clin Oncol. 2023;41:4905-4915.
    PubMed     Abstract available
    
    
    August 2023
19. NARDONE V, Meirson T, De Felice F, Meattini I, et al
    Genomic Profiling: Can We Rely on Retrospective Analysis to Drive Changes in Clinical Practice?
    J Clin Oncol. 2023;41:3957-3958.
    PubMed    
    
    
    
20. ANDO Y, Terada T
    Consent in Pharmacogenetic Testing.
    J Clin Oncol. 2023;41:3875.
    PubMed    
    
    
    July 2023
21. STRACH MC, Mahon K, Barriuso J
    Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?
    J Clin Oncol. 2023;41:3559.
    PubMed    
    
    
    June 2023
22. SUBBIAH V, Kurzrock R
    Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis.
    J Clin Oncol. 2023;41:3100-3103.
    PubMed    
    
    
    May 2023
23. KINNEY AY, Walters ST, Lin Y, Lu SE, et al
    Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
    J Clin Oncol. 2023;41:2767-2778.
    PubMed     Abstract available
    
    
    January 2023
24. YU Y, Shi Q, Chen H
    Acquired Genomic Alterations From First-Line Anti-EGFR Chemotherapy in Advanced Colorectal Cancer: Improving Study Design and Data Analysis.
    J Clin Oncol. 2023 Jan 3:JCO2202296. doi: 10.1200/JCO.22.02296.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum